These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26233853)

  • 1. Determined to Fail--the Role of Genetic Mechanisms in Heart Failure.
    Kayvanpour E; Katus HA; Meder B
    Curr Heart Fail Rep; 2015 Oct; 12(5):333-8. PubMed ID: 26233853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Has the time come for genetic diagnostics in heart failure?].
    Straburzyńska-Migaj E
    Kardiol Pol; 2007 Jan; 65(1):63-70. PubMed ID: 17295164
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart failure: advanced development in genetics and epigenetics.
    Yang J; Xu WW; Hu SJ
    Biomed Res Int; 2015; 2015():352734. PubMed ID: 25949994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of dilated cardiomyopathy.
    Fatkin D; Otway R; Richmond Z
    Heart Fail Clin; 2010 Apr; 6(2):129-40. PubMed ID: 20347783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to heart failure.
    Pasotti M; Repetto A; Tavazzi L; Arbustini E
    Med Clin North Am; 2004 Sep; 88(5):1173-92. PubMed ID: 15331312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system gene polymorphisms as potential modifiers of hypertrophic and dilated cardiomyopathy phenotypes.
    Rani B; Kumar A; Bahl A; Sharma R; Prasad R; Khullar M
    Mol Cell Biochem; 2017 Mar; 427(1-2):1-11. PubMed ID: 28120210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
    Feldman AM; Wagner DR; McNamara DM
    Circulation; 1999 Mar; 99(11):1397-9. PubMed ID: 10086958
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between polymorphisms of the HSPB7 gene and Cheyne-Stokes respiration with central sleep apnea in patients with dilated cardiomyopathy and congestive heart failure.
    Wang M; Ding H; Kang J; Hu K; Lu W; Zhou X; Xu L
    Int J Cardiol; 2016 Oct; 221():926-31. PubMed ID: 27441470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes and their polymorphisms in mono- and multifactorial cardiomyopathies: towards pharmacogenomics in heart failure.
    Charron P; Komajda M
    Pharmacogenomics; 2002 May; 3(3):367-78. PubMed ID: 12052144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a missense mutation in the melusin-encoding ITGB1BP2 gene in a patient with dilated cardiomyopathy.
    Ruppert V; Meyer T; Richter A; Maisch B; Pankuweit S;
    Gene; 2013 Jan; 512(2):206-10. PubMed ID: 23124043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms and heart failure.
    Bleumink GS; Schut AF; Sturkenboom MC; Deckers JW; van Duijn CM; Stricker BH
    Genet Med; 2004; 6(6):465-74. PubMed ID: 15545741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of dilated cardiomyopathy: practical implications for heart failure management.
    Rosenbaum AN; Agre KE; Pereira NL
    Nat Rev Cardiol; 2020 May; 17(5):286-297. PubMed ID: 31605094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
    Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
    Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congestive heart failure is a common disease with complex inheritance--new perspectives through genome wide association studies].
    Linsel-Nitschke P; Schunkert H; Erdmann J
    Internist (Berl); 2008 Apr; 49(4):405-10, 412. PubMed ID: 18301871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and heart failure: a concise guide for the clinician.
    Skrzynia C; Berg JS; Willis MS; Jensen BC
    Curr Cardiol Rev; 2015; 11(1):10-7. PubMed ID: 24251456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of morpho-functional parameters of the heart and polymorphisms of Renin-Angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy].
    Belenkov YN; Privalova EV; Kaplunova VY; Stambol'skiĭ DV; Fomin AA
    Kardiologiia; 2010; 50(6):27-34. PubMed ID: 20659024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial dilated cardiomyopathy].
    Osterziel KJ; Hassfeld S; Geier C; Perrot A
    Herz; 2005 Sep; 30(6):529-34. PubMed ID: 16170685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha 2C Del322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans.
    Du Preez J; Matolweni LO; Greenberg J; Mntla P; Adeyemo AA; Mayosi BM
    Cardiovasc J Afr; 2008; 19(1):15-6. PubMed ID: 18320080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The family history as a tool to identify patients at risk for dilated cardiomyopathy.
    Nauman D; Morales A; Cowan J; Dagua J; Hershberger RE
    Prog Cardiovasc Nurs; 2008; 23(1):41-4. PubMed ID: 18326985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.